Exhale

The official blog of the Lung Institute.

The Difference between Emphysema and Chronic Bronchitis

5 Nov 2014
| Under Chronic Bronchitis, COPD, Lung Disease, Related Conditions | Posted by
| 31 Comments
The difference between emphysema and chronic bronchitis

Emphysema and chronic bronchitis are different types of chronic obstructive pulmonary disease (COPD). With COPD, the lungs have developed permanent complications that affect the ease with which a person can breathe. Although COPD has no cure, there are now advancements in the form of cellular therapy that may help.

Is it Emphysema or Chronic Bronchitis?

Emphysema and chronic bronchitis can be difficult to tell apart, but each presents problems with breathing and other lung symptoms. These conditions commonly affect normal airflow in the airways and lungs. They are usually caused by smoking, but can also be attributed to air pollution.

Emphysema involves the gradual destruction of the air sacs in the lungs (alveoli), hindering breathing. Alveoli are responsible for providing oxygen to the bloodstream. Over time, emphysema  weakens the alveoli and destroys the elasticity of pulmonary airways. As a result, emphysema sufferers experience shortness of breath and a constant struggle to breathe.

Bronchitis

Chronic bronchitis is the opposite of emphysema. This condition causes a person’s lungs to become very inflamed. Bronchitis commonly affects the windpipe and passageways of the lungs and is the result of severe irritation or infection. It can be a brief illness, or ongoing (chronic). The body’s natural reaction to chronic bronchitis is to clear the air passages, resulting in severe coughing.

The difference between emphysema and chronic bronchitis lies in how each disease affects the lungs. The lack of a cure for either emphysema or chronic bronchitis doesn’t mean a lack of available treatment.

If you have exhausted conventional medical treatments and are looking for alternatives, cellular therapy may be a viable option for you. If you or a loved one is interested in cellular therapy for lung disease, contact the Lung Institute to learn more or call 888-745-6697.

* Every patient is given a Patient Satisfaction Survey shortly after treatment. Responses to the 11-question survey are aggregated to determine patient satisfaction with the delivery of treatment.

^ Quality of Life Survey data measured the patient’s self-assessed quality of life and measurable quality of improvement at three months of COPD patients.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.

Each patient is different. Results may vary.